Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook 
Italy Investigates Microsoft Over Microsoft 365 AI Subscription Price Hike 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
Cerebras Revenue Forecast Tops Expectations, but Margin Concerns Weigh on Stock 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
China Eastern Orders 25 Airbus A330neo Jets in $9.35 Billion Deal to Boost International Expansion 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Anthropic AI Model Uncovers Vulnerabilities in Classified U.S. Government Systems During Security Test 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
Alphabet Replaces Verizon in Dow Jones Industrial Average 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Sanofi (NASDAQ:SNY), in partnership with Vietnam Vaccine JSC (VNVC), officially launched a state-of-the-art vaccine production facility in Vietnam, marking a major step in boosting the country’s pharmaceutical manufacturing capabilities. The new plant is designed to supply vaccines for both domestic distribution and global export, supporting broader public health goals across Asia and beyond.
The inauguration ceremony, held on Tuesday, was attended by French President Emmanuel Macron during his diplomatic visit to the Southeast Asian nation, underscoring the importance of international collaboration in advancing healthcare access.
Strategically located to serve Vietnam’s growing healthcare needs, the facility enhances local vaccine self-sufficiency while contributing to the global vaccine supply chain. It is part of Sanofi’s ongoing effort to expand its footprint in emerging markets and reinforce its role as a global vaccine leader.
The launch comes amid heightened global attention on vaccine access and preparedness following recent pandemics. By leveraging cutting-edge technology and Sanofi’s extensive vaccine expertise, the facility aims to strengthen Vietnam’s position as a regional hub for pharmaceutical innovation and production.
This initiative reflects Sanofi’s commitment to investing in sustainable healthcare infrastructure and VNVC’s mission to improve immunization access across Vietnam. The collaboration also aligns with government goals to attract high-quality foreign investment in biotechnology and life sciences.
With the new facility operational, Sanofi and VNVC are well-positioned to meet growing demand for essential vaccines, not only within Vietnam but across neighboring countries, contributing to improved regional health outcomes.
The opening of this manufacturing site marks a significant milestone in Vietnam’s healthcare development, offering long-term benefits in vaccine accessibility, economic growth, and international cooperation in the pharmaceutical sector.
